N. Quan et al., Induction of I kappa B alpha mRNA expression in the brain by glucocorticoids: A negative feedback mechanism for immune-to-brain signaling, J NEUROSC, 20(17), 2000, pp. 6473-6477
Peripheral injection of bacterial endotoxin lipopolysaccharide (LPS) induce
s brain mRNA expression of the proinflammatory cytokines interleukin-1 beta
(IL-1 beta) and tumor necrosis factor-alpha and the cytokine-responsive im
mediate-early gene I kappa B alpha. Peripheral LPS also increases levels of
plasma glucocorticoids. Whether the induction of I kappa B alpha mRNA in t
he brain after peripheral LPS injection is caused by the feedback action of
glucocorticoids has not been determined. In this study, we examined the mR
NA expression of I kappa B alpha and IL-1 beta in the rat brain by in situ
hybridization histochemistry. Injection of the glucocorticoid agonist dexam
ethasone induced I kappa B alpha mRNA expression in the brain in a pattern
identical to that of LPS injection. LPS but not dexamethasone also induced
IL-1 beta mRNA expression. Pretreatment with dexamethasone 30 min before LP
S injection enhanced the expression of I kappa B alpha mRNA in the brain in
a dose-dependent manner. Immobilization of rats for 2 hr (which raises glu
cocorticoid levels) also induced I kappa B alpha mRNA expression without in
ducing the expression of IL-1 beta. Brain I kappa B alpha expression induce
d by peripheral LPS injection was attenuated by pretreatment of rats with t
he glucocorticoid antagonist RU-486. Finally, increased expression of IL-1
beta mRNA in the brain was observed at 4 hr after peripheral LPS injection
in adrenalectomized rats compared with sham-operated rats. These results re
veal that in the brain glucocorticoids selectively induce I kappa B alpha m
RNA expression, which serves as a negative feedback mechanism for periphera
l LPS-induced synthesis of proinflammatory cytokines. Such an inhibitory co
ntrol mechanism may be important for preventing prolonged expression of pro
inflammatory cytokines in the brain after peripheral immune challenge.